The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Subsequent primary malignancies (SPMs) after diffuse large B-cell lymphoma (DLBCL) in the modern treatment era.
 
Theresa H.M. Keegan
No Relationships to Disclose
 
Christina A Clarke
Leadership - Healthline (I)
Stock and Other Ownership Interests - Healthline (I); Tonic Health Solutions
Research Funding - Genentech (Inst)
Travel, Accommodations, Expenses - Genentech
 
Aaron Seth Rosenberg
No Relationships to Disclose
 
Ranjana H. Advani
Honoraria - GE Healthcare
Consulting or Advisory Role - Forty Seven; Genentech/Roche; Kyowa Hakko Kirin
Research Funding - Agensys (Inst); Allos Therapeutics (Inst); Celgene (Inst); Genentech/Roche (Inst); Idera (Inst); Infinity Pharmaceuticals; Janssen (Inst); Kura Oncology; Merck; Millennium (Inst); Pharmacyclics (Inst); Regeneron; Seagen (Inst)
Travel, Accommodations, Expenses - Kyowa Hakko Kirin; Seagen
 
Brian Andrew Jonas
Consulting or Advisory Role - Glycomimetics; Rigel
Speakers' Bureau - Celgene; Incyte; Onyx
Research Funding - Abbvie (Inst); Ambit BioSciences (Inst); Daiichi Sankyo (Inst); Esanex (Inst); KaloBios (Inst); Pharmacyclics (Inst); Sigma-Tau (Inst)
 
Christopher Flowers
Consulting or Advisory Role - OptumRx; Seagen
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); Celgene (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Infinity Pharmaceuticals (Inst); Janssen Oncology (Inst); Onyx (Inst); Pharmacyclics (Inst); Spectrum Pharmaceuticals (Inst); TG Therapeutics (Inst)
Travel, Accommodations, Expenses - Celgene; Genentech/Roche; Gilead Sciences
 
Li Tao
No Relationships to Disclose